A National Cancer Institute Comprehensive Cancer Center

 
 

Health Encyclopedia

 

 

Nonmelanoma Skin Cancer: Photodynamic Therapy

Topic Overview

Photodynamic therapy (PDT) is being studied as a treatment for nonmelanoma skin cancer. PDT is a process of applying a medicine to a skin cancer and then shining a special laser light on it.

Results of early studies with the medicine 5-aminolevulinic acid (ALA) show that topical PDT may be effective in treating actinic keratoses on the face and scalp, squamous cell carcinoma in situ (Bowen's disease), and superficial basal cell carcinomas. Studies report good results with skin appearance after treatment and a low rate of side effects.1

Studies of PDT with methyl aminolevulinate (MAL) found that this treatment was as effective as cryosurgery for actinic keratoses and squamous cell carcinoma in situ (Bowen's disease).2

Related Information

References

Citations

  1. Liu H, et al. (2004). Photodynamic therapy of multiple nonmelanoma skin cancers with verteprofin and red light-emitting diodes: Two-year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology, 140(1): 26–32.
  2. National Comprehensive Cancer Network (2010). Basal cell and squamous cell skin cancers. NCCN Clinical Practice Guidelines in Oncology, Version 1. Available online: http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf.

Credits

By Healthwise Staff
Primary Medical Reviewer Kathleen Romito, MD - Family Medicine
Specialist Medical Reviewer Randall D. Burr, MD - Dermatology
Last Revised October 1, 2010

Last Revised: October 1, 2010

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.